Preventive treatment of tripdiolide ameliorates kidney injury in diabetic mice by modulating the Nrf2/NF-κB pathway
Bo Yuan,
No information about this author
Dan Jia,
No information about this author
Baoshan Gao
No information about this author
et al.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: March 19, 2025
Introduction
Although
tripdiolide
has
demonstrated
a
protective
role
in
lupus
nephritis,
its
potential
therapeutic
and
preventive
effects
on
diabetic
kidney
injury
remain
inconclusive.
Methods
In
this
study,
diabetes
mice
model
was
used
to
evaluate
the
effect
of
treatment
kidney.
The
study
assessed
related
factors
levels,
while
comparing
pathological
changes,
alterations
intestinal
microbiota
composition,
oxidative
stress
inflammation
kidneys,
validating
cytokine
expression
protein
pathway
activation.
Results
experiment
that
effectively
suppressed
hyperglycemia
elevated
hemoglobin
level,
attenuated
concentrations
creatinine
blood
urea
nitrogen,
mitigated
histopathological
kidney,
alleviated
inflammatory
cell
infiltration.
Tripdiolide
regulated
affected
abundance
Allobaculum
,
Dubosella
Prevotella
differential
metabolic
pathways
primarily
revolve
around
ubiquinol
biosynthesis
menaquinol
biosynthesis.
significantly
renal
mice,
as
evidenced
by
upregulation
nuclear
factor
erythroid
2-related
2
(Nrf2),
heme
Oxygenase-1,
downregulation
phosphorylated
factor-κB
(P-NF-κB),
NOD-like
receptor
3.
Experiments
performed
RAW264.7
cells
tripdiolide.
Discussion
may
play
induced
changing
composition
microorganisms,
regulating
Nrf2/NF-κB
activation,
inhibiting
reaction.
This
contributes
scientific
evidence
can
inform
development
approaches
for
nephropathy.
Language: Английский
Diphenyl diselenide protects against diabetic kidney disease through modulating gut microbiota dysbiosis in streptozotocin-induced diabetic rats
Xing Wang,
No information about this author
Dongmei Long,
No information about this author
Peng Xie
No information about this author
et al.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: Dec. 3, 2024
Diphenyl
diselenide
(DPDS)
ameliorates
nephropathy
in
streptozotocin
(STZ)-induced
type
1
diabetic
rats
by
inhibiting
oxidative
stress
and
inflammatory
reactions.
However,
it
has
not
been
clarified
whether
DPDS
alleviates
kidney
disease
(DKD)
is
related
to
the
inhibition
of
extracellular
matrix
(ECM)
production
regulation
intestinal
flora
disorder.
Language: Английский